This study aims to (1) obtain a pure extract of Sargassumfilipendula fucoxanthin, (2) determine the effect of concentration of fucoxanthin against HeLa cells, and (3) determine the effect of concentration of fuc...This study aims to (1) obtain a pure extract of Sargassumfilipendula fucoxanthin, (2) determine the effect of concentration of fucoxanthin against HeLa cells, and (3) determine the effect of concentration of fucoxanthin against cancer cell lymphocytes. The benefit of this research is to find out that fucoxanthin can be used as an anti-cancer treatment. The study was conducted in September 2013 at the Laboratory of Fishery Product Technology FPIK UB and UB Medical Biomedical Laboratories, Malang. Sampling brown seaweed (Sargassum filipendula) of the District Rural Padike Talango Sumenep Madura. Extracted isolated by column chromatography using silica gel stationary phase and mobile phase hexane:ethyl acetate (6:4, v/v) ± 100 mL, then identified by TLC using the stationary phase, a silica gel F-254 HPLC with ODS stationary phase (C-18) 5 mL with a mobile phase of methanol, acetone and ammonium acetate (IM) (80:10:10, v/v) and a flow rate of 1.0 mL/min pigment solution of 20 mL compared with the standard of Japan. Research results indicate that, spectra maximum wavelength of 450 nm and 446 nm with a minimum of acetone solvent. HPLC has the same retention time = 10.12 standard, namely Sargassum filipendula = 10.11. By giving some of the best concentrations at 100 ppm is lethal HeLa cells ebesar 5236% which means that fucoxanthin effect against HeLa cells have the potential fucoxanthin that can induce cell apoptosis that occurs in HeLa cells, it is possible because of the anti-carcinogenic fucoxanthin mempuyai structure unique. While the cell lymphocytes in the dosage of 100 ppm were dead at 8.788%, the effect of the toxicity of a substance can be observed from how many dead lymphocytes when compared with the state charity by observing level of lymphocyte proliferation.展开更多
文摘This study aims to (1) obtain a pure extract of Sargassumfilipendula fucoxanthin, (2) determine the effect of concentration of fucoxanthin against HeLa cells, and (3) determine the effect of concentration of fucoxanthin against cancer cell lymphocytes. The benefit of this research is to find out that fucoxanthin can be used as an anti-cancer treatment. The study was conducted in September 2013 at the Laboratory of Fishery Product Technology FPIK UB and UB Medical Biomedical Laboratories, Malang. Sampling brown seaweed (Sargassum filipendula) of the District Rural Padike Talango Sumenep Madura. Extracted isolated by column chromatography using silica gel stationary phase and mobile phase hexane:ethyl acetate (6:4, v/v) ± 100 mL, then identified by TLC using the stationary phase, a silica gel F-254 HPLC with ODS stationary phase (C-18) 5 mL with a mobile phase of methanol, acetone and ammonium acetate (IM) (80:10:10, v/v) and a flow rate of 1.0 mL/min pigment solution of 20 mL compared with the standard of Japan. Research results indicate that, spectra maximum wavelength of 450 nm and 446 nm with a minimum of acetone solvent. HPLC has the same retention time = 10.12 standard, namely Sargassum filipendula = 10.11. By giving some of the best concentrations at 100 ppm is lethal HeLa cells ebesar 5236% which means that fucoxanthin effect against HeLa cells have the potential fucoxanthin that can induce cell apoptosis that occurs in HeLa cells, it is possible because of the anti-carcinogenic fucoxanthin mempuyai structure unique. While the cell lymphocytes in the dosage of 100 ppm were dead at 8.788%, the effect of the toxicity of a substance can be observed from how many dead lymphocytes when compared with the state charity by observing level of lymphocyte proliferation.